174 related articles for article (PubMed ID: 31468156)
1. Evidence-based MR imaging follow-up strategy for desmoid-type fibromatosis.
Gondim Teixeira PA; Biouichi H; Abou Arab W; Rios M; Sirveaux F; Hossu G; Blum A
Eur Radiol; 2020 Feb; 30(2):895-902. PubMed ID: 31468156
[TBL] [Abstract][Full Text] [Related]
2. Correlation between tumor growth and hormonal therapy with MR signal characteristics of desmoid-type fibromatosis: A preliminary study.
Gondim Teixeira PA; Chanson A; Verhaeghe JL; Lecocq S; Louis M; Hossu G; Blum A
Diagn Interv Imaging; 2019 Jan; 100(1):47-55. PubMed ID: 30037746
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid-type fibromatosis.
Zanchetta E; Ciniselli CM; Bardelli A; Colombo C; Stacchiotti S; Baldi GG; Provenzano S; Bertulli R; Bini F; Casale A; Greco FG; Ferrari A; Verderio P; Fiore M; Gronchi A; Casali PG; Morosi C; Palassini E
Cancer Med; 2021 Jul; 10(13):4356-4365. PubMed ID: 34102009
[TBL] [Abstract][Full Text] [Related]
4. The value of the black fiber sign on T1-weighted images for predicting stability of desmoid fibromatosis managed conservatively.
Murahashi Y; Emori M; Shimizu J; Anzai K; Tanaka T; Naka N; Tsuchie H; Nagasawa H; Miyakoshi N; Shimada Y; Yamashita T
Eur Radiol; 2020 Oct; 30(10):5768-5776. PubMed ID: 32435931
[TBL] [Abstract][Full Text] [Related]
5. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI.
Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA
Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110
[TBL] [Abstract][Full Text] [Related]
6. Desmoid-type fibromatosis in the head and neck: CT and MR imaging characteristics.
Rhim JH; Kim JH; Moon KC; Park SW; Sohn CH; Choi SH; Yun TJ; Chang KH
Neuroradiology; 2013 Feb; 55(3):351-9. PubMed ID: 23338838
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of apatinib for patients with advanced extremity desmoid fibromatosis: a retrospective study.
Zheng C; Fang J; Wang Y; Zhou Y; Tu C; Min L
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2127-2135. PubMed ID: 33452581
[TBL] [Abstract][Full Text] [Related]
8. [Magnetic resonance imaging of desmoid-type fibromatosis: Current evaluation criteria].
Ben Haj Amor M; Ploton L; Ceugnart L; Taïeb S
Bull Cancer; 2020 Mar; 107(3):359-363. PubMed ID: 32008700
[TBL] [Abstract][Full Text] [Related]
9. Desmoid fibromatosis: MRI features of response to systemic therapy.
Sheth PJ; Del Moral S; Wilky BA; Trent JC; Cohen J; Rosenberg AE; Temple HT; Subhawong TK
Skeletal Radiol; 2016 Oct; 45(10):1365-73. PubMed ID: 27502790
[TBL] [Abstract][Full Text] [Related]
10. MRI characteristics predict the efficacy of meloxicam treatment in patients with desmoid-type fibromatosis.
Shimizu K; Hamada S; Sakai T; Ito S; Urakawa H; Arai E; Ikuta K; Koike H; Ishiguro N; Nishida Y
J Med Imaging Radiat Oncol; 2019 Dec; 63(6):751-757. PubMed ID: 31448875
[TBL] [Abstract][Full Text] [Related]
11. Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort Study.
Cassidy MR; Lefkowitz RA; Long N; Qin LX; Kirane A; Sbaity E; Hameed M; Coit DG; Brennan MF; Singer S; Crago AM
Ann Surg; 2020 Apr; 271(4):748-755. PubMed ID: 30418203
[TBL] [Abstract][Full Text] [Related]
12. MRI and biologic behavior of desmoid tumors in children.
McCarville MB; Hoffer FA; Adelman CS; Khoury JD; Li C; Skapek SX
AJR Am J Roentgenol; 2007 Sep; 189(3):633-40. PubMed ID: 17715111
[TBL] [Abstract][Full Text] [Related]
13. Aggressive fibromatosis: MRI features with pathologic correlation.
Lee JC; Thomas JM; Phillips S; Fisher C; Moskovic E
AJR Am J Roentgenol; 2006 Jan; 186(1):247-54. PubMed ID: 16357411
[TBL] [Abstract][Full Text] [Related]
14. [Imaging manifestations and pathologic features of soft tissue desmoid-type fibromatosis].
Liu QY; Chen JY; Liang BL; Li HG; Gao M; Lin XF
Ai Zheng; 2008 Dec; 27(12):1287-92. PubMed ID: 19079995
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance-guided focused ultrasound treatment of extra-abdominal desmoid tumors: a retrospective multicenter study.
Ghanouni P; Dobrotwir A; Bazzocchi A; Bucknor M; Bitton R; Rosenberg J; Telischak K; Busacca M; Ferrari S; Albisinni U; Walters S; Gold G; Ganjoo K; Napoli A; Pauly KB; Avedian R
Eur Radiol; 2017 Feb; 27(2):732-740. PubMed ID: 27147222
[TBL] [Abstract][Full Text] [Related]
16. Can the MRI signal of aggressive fibromatosis be used to predict its behavior?
Castellazzi G; Vanel D; Le Cesne A; Le Pechoux C; Caillet H; Perona F; Bonvalot S
Eur J Radiol; 2009 Feb; 69(2):222-9. PubMed ID: 19046842
[TBL] [Abstract][Full Text] [Related]
17. MRI T2 mapping assessment of T2 relaxation time in desmoid tumors as a quantitative imaging biomarker of tumor response: preliminary results.
Souza FF; D'Amato G; Jonczak EE; Costa P; Trent JC; Rosenberg AE; Yechieli R; Temple HT; Pattany P; Subhawong TK
Front Oncol; 2023; 13():1286807. PubMed ID: 38188297
[TBL] [Abstract][Full Text] [Related]
18. Desmoid-type fibromatosis of the lower extremity: A unique case of complete lesion resolution following core needle biopsy.
Tafti D; Kao E; Alderete JF; Cecava ND
Clin Imaging; 2021 Jan; 69():213-218. PubMed ID: 32920469
[TBL] [Abstract][Full Text] [Related]
19. Multi-parametric (mp) MRI for the diagnosis of abdominal wall desmoid tumors.
Khanna M; Ramanathan S; Kambal AS; Al-Berawi M; Yadav S; Kumar D; Schieda N
Eur J Radiol; 2017 Jul; 92():103-110. PubMed ID: 28624006
[TBL] [Abstract][Full Text] [Related]
20. Extra-abdominal desmoid fibromatosis--a sarcoma unit review of practice, long term recurrence rates and survival.
Eastley N; Aujla R; Silk R; Richards CJ; McCulloch TA; Esler CP; Ashford RU
Eur J Surg Oncol; 2014 Sep; 40(9):1125-30. PubMed ID: 24612653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
